Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03436979 · ClinicalTrials.gov registry record
The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse
A clinical trial of Uterine Prolapse Without Vaginal Wall Prolapse, sponsored by Pop Medical Solutions.
- Completed
- Registry status
- 60
- Enrollment target
- 15
- Study locations
NCT03436979: Completed study of Uterine Prolapse Without Vaginal Wall Prolapse, sponsored by Pop Medical Solutions.
NCT03436979 is a study of Uterine Prolapse Without Vaginal Wall Prolapse that has completed, run by Pop Medical Solutions. The registered enrollment target is 60 participants. The trial reports 15 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03436979, a study of Uterine Prolapse Without Vaginal Wall Prolapse, has completed, sponsored by Pop Medical Solutions.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 15
- Study locations
Study Summary
The objective of the study is to assess the long term safety, durability of clinical effectiveness and cost effectiveness of the NeuGuide™ system when used for vaginal colpopexy in the treatment of uterine prolapse.
Primary Outcome
Primary composite performance outcome
Conditions Studied
Interventions
- DEVICE NeuGuide™ System
Study Locations (15)
Other
- Krankenhaus Waldfriede - Berlin-Zehlendorf
- Isar Kliniken GmbH - München
- St. Joseph Krankenhaus - Tempelhof
- Soroka Medical Center - Beersheba
Florida
- Holy Cross Hospital - Fort Lauderdale
- Cleveland Clinic Florida - Weston
New York
- Maimonides Medical Center - Brooklyn
- South Nassau Community Hospital Cancer Center - Valley Stream
Pennsylvania
- The Institute for Female Pelvic Medicine and Reconstructive Surgery - Allentown
- Female Pelvic Health Center - Newtown
District of Columbia
- MedStar Health Research Institute - Washington D.C.
Massachusetts
- Mount Auburn Hospital - Cambridge
Ohio
- Cleveland Clinic Cleveland - Cleveland
Texas
- Walnut Hill OB/GYN Associates - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2023-10-31 |
What the finished NCT03436979 record still lists
NCT03436979 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 1 condition, with Uterine Prolapse Without Vaginal Wall Prolapse appearing as the primary indexed condition, and to 1 intervention - of which NeuGuide™ System is the first listed.
NCT03436979 lists 15 locations in 9 states (Other, Florida, New York).
Frequently Asked Questions
What is clinical trial NCT03436979 about?
NCT03436979 is a clinical study titled "The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse". The objective of the study is to assess the long term safety, durability of clinical effectiveness and cost effectiveness of the NeuGuide™ system when used for vaginal colpopexy in the treatment of uterine prolapse.
What is the current status of trial NCT03436979?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2018-01-01. Estimated completion is 2023-10-31.
What conditions does trial NCT03436979 study?
This clinical trial studies the following conditions: Uterine Prolapse Without Vaginal Wall Prolapse.
What interventions are being tested in trial NCT03436979?
The interventions under investigation include: NeuGuide™ System (DEVICE).
Who is sponsoring clinical trial NCT03436979?
This trial is sponsored by Pop Medical Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03436979 being conducted?
This trial has 15 study locations across District of Columbia, Florida, Massachusetts, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI